Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.S.

Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.S.

Non-cystic fibrosis bronchiectasis (NCFBE) is a rare, chronic lung disease characterized by bronchial inflammation and permanent airway dilation. Chronic infections with P. aeruginosa have been linked to higher morbidity and mortality. To understand the impact of P. aeruginosa in NCFBE on health car...

Full description

Bibliographic Details
Main Authors: Christopher M. Blanchette, Joshua M. Noone, Glenda Stone, Emily Zacherle, Ripsi P. Patel, Reuben Howden, Douglas Mapel
Format: Article
Language:English
Published: MDPI AG 2017-09-01
Series:Medical Sciences
Subjects:
bronchiectasis
Pseudomonas aeruginosa
healthcare costs
healthcare utilization
exacerbations
chronic lung disease
bronchial inflammation
Online Access:https://www.mdpi.com/2076-3271/5/4/20

Internet

https://www.mdpi.com/2076-3271/5/4/20

Similar Items